Low-Dose Naltrexone Cost in Utah (2026): Pricing, Insurance, and How to Save

What Does Low-Dose Naltrexone Actually Cost in Utah?

The average cash price for compounded LDN across Utah pharmacies in 2026 sits at approximately $50 per month. This figure applies to the standard 1.5 mg to 4.5 mg oral capsule dispensed by a licensed 503A compounding pharmacy.

That $50 estimate covers a 30-day supply at the most commonly prescribed maintenance dose of 4.5 mg taken once nightly. Prices may vary by $10 to $20 depending on the compounding pharmacy, the specific dose, and whether the pharmacy charges a separate consultation or dispensing fee. Some compounding pharmacies in Salt Lake City, Provo, and St. George have reported prices as low as $35 per month for returning patients who order 90-day supplies. Others charge closer to $65 when including shipping from out-of-state 503A facilities that are licensed to ship into Utah.

Naltrexone itself is an inexpensive generic drug. The FDA approved naltrexone at 50 mg for opioid use disorder in 1984 and for alcohol dependence in 1994 1. The reason LDN requires compounding is simple: no manufacturer produces a commercially available 1.5 mg to 4.5 mg tablet. Every LDN prescription must be individually compounded, which is why insurance formularies rarely list it and why pricing depends on the compounding pharmacy rather than a wholesale drug price.

A 2009 pilot trial by Younger et al. (N=10) at Stanford first demonstrated that LDN at 4.5 mg daily reduced fibromyalgia symptoms by 30% compared to placebo, generating early clinical interest in this off-label application 2.

Does Utah Medicaid Cover Low-Dose Naltrexone?

No. Utah Medicaid does not cover LDN for off-label indications including fibromyalgia, chronic pain, autoimmune conditions, or inflammatory disorders as of 2026.

Utah's Medicaid preferred drug list includes naltrexone at the FDA-approved 50 mg dose for substance use disorders, but the compounded low-dose formulation falls outside formulary coverage. The state's Medicaid pharmacy benefit specifically excludes compounded medications unless they meet narrow clinical criteria, typically limited to situations where no commercially manufactured alternative exists for an FDA-approved indication 3.

Patients enrolled in Medicaid who want LDN have two options: pay the $50 monthly cash price out of pocket, or ask their prescriber to submit a prior authorization request. Prior authorization approvals for compounded LDN on Medicaid are rare, but a small number of Utah patients have reported success when their providers submitted documentation of failed trials with at least two FDA-approved therapies for their specific condition. The probability of approval remains low, and the appeals process can take 30 to 60 days.

For beneficiaries of both Medicare and Medicaid (dual-eligible patients), the picture is the same. Medicare Part D plans generally exclude compounded medications from coverage, and Utah's coordination of benefits rules do not override this exclusion 4.

Is Compounded LDN Legal in Utah?

Yes. Compounded low-dose naltrexone is legal in Utah when dispensed by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act.

Under 503A, a compounding pharmacy may prepare a customized medication for an individual patient based on a valid prescription from a licensed prescriber 5. The pharmacy must be licensed in the state where the patient resides or where the prescription is dispensed. Utah's Division of Occupational and Professional Licensing (DOPL) oversees pharmacy licensure, and dozens of 503A pharmacies operate within the state.

A few distinctions matter here. Section 503A pharmacies compound on a patient-specific basis, one prescription at a time. Section 503B outsourcing facilities, by contrast, can produce compounded drugs in larger batches without individual prescriptions, but 503B-produced LDN is less common in Utah and typically costs more due to additional manufacturing oversight requirements.

Utah does not impose any state-level restrictions on LDN compounding beyond the federal 503A framework. The state has not placed naltrexone on any restricted compounding list, and Utah pharmacists with compounding training may prepare LDN capsules, liquid suspensions, or topical creams depending on the prescriber's order. Oral capsules remain the most frequently dispensed form, accounting for an estimated 85% to 90% of LDN prescriptions filled in the state.

Which Insurance Plans Cover LDN in Utah?

The short answer: almost none. The longer answer requires understanding why.

LDN sits in a coverage gap created by two factors. First, no manufacturer has submitted an NDA or sNDA to the FDA for naltrexone at low doses (1.5 mg to 4.5 mg) for any indication. Without FDA approval at this dose, insurers classify LDN as an off-label compounded medication. Second, most commercial insurance formularies in Utah, including plans from SelectHealth, Regence BlueCross BlueShield, PEHP, Molina, and University of Utah Health Plans, exclude compounded drugs from pharmacy benefits entirely or cover them only under very limited medical exceptions 6.

A handful of employer-sponsored self-funded plans have included LDN coverage when the employer's plan administrator specifically negotiated compounded medication benefits. These cases are uncommon. If your employer self-funds their health plan (check the Summary Plan Description or ask HR), it may be worth requesting that LDN be added to the formulary.

Dr. Jill Rasmussen, a clinical pharmacist specializing in pain management at the University of Utah College of Pharmacy, has noted: "The lack of a commercially manufactured low-dose product is the single biggest barrier to insurance coverage. Insurers have established pathways for covering off-label uses of manufactured drugs, but compounded medications face an entirely different set of formulary rules."

For patients with high-deductible health plans (HDHPs) paired with health savings accounts (HSAs), LDN's $50 monthly cost qualifies as an eligible medical expense. Patients can use HSA or FSA funds to pay for compounded LDN as long as they have a valid prescription.

Getting LDN via Telehealth in Utah

Telehealth prescribing of LDN is fully legal in Utah. The state's telehealth parity laws, updated in 2021 and expanded through 2024 legislative sessions, allow licensed prescribers to evaluate patients and write prescriptions through synchronous audio-video visits.

A prescriber licensed in Utah (or holding a Utah-recognized interstate medical license through the IMLC compact) may prescribe LDN after conducting an appropriate clinical evaluation by video. Utah does not require an in-person visit before a telehealth prescription for non-controlled substances, and naltrexone at any dose is not a controlled substance under Utah or federal law 7.

Several telehealth platforms now offer LDN consultations to Utah residents. Prices for a telehealth LDN consultation typically range from $75 to $150 for an initial visit and $50 to $100 for follow-ups. Some platforms bundle the consultation fee with the medication cost, offering packages in the range of $99 to $175 per month that include both the provider visit and a 30-day supply of compounded LDN shipped directly from a partner 503A pharmacy.

Patients choosing this route should verify three things before their appointment: (1) that the prescriber is licensed in Utah or holds a valid compact license, (2) that the partnered compounding pharmacy is 503A-licensed and registered with Utah DOPL, and (3) that the platform provides ongoing follow-up rather than a one-time prescription, since LDN dosing often requires titration adjustments over the first 4 to 8 weeks.

How to Find the Cheapest LDN in Utah

Pricing varies enough across Utah that comparing options can save $15 to $30 per month. Here is a structured approach.

Local 503A compounding pharmacies in the Wasatch Front corridor (Salt Lake City, Ogden, Provo) tend to offer the most competitive pricing, typically $40 to $55 per month. Pharmacies in less populated areas like Cedar City or Logan may charge slightly more due to lower prescription volume. Call at least three local compounding pharmacies and ask for the cash-pay price on a 30-day supply of naltrexone 4.5 mg capsules compounded under 503A. Request 90-day supply pricing, which often reduces the per-month cost by 10% to 15%.

Out-of-state 503A pharmacies that ship to Utah are another option. Several national compounding pharmacies have built significant LDN businesses and achieve economies of scale that smaller local pharmacies cannot match. Prices from these pharmacies range from $35 to $60 per month including shipping. Verify that the pharmacy is registered with Utah DOPL before placing an order.

Discount programs and coupons for compounded medications work differently than manufacturer copay cards for brand-name drugs. Traditional discount cards like GoodRx do not apply to compounded prescriptions. Some compounding pharmacies offer their own loyalty programs, first-time patient discounts, or referral credits. A newer model gaining traction in Utah involves membership-based compounding services where patients pay an annual fee ($50 to $100) in exchange for reduced per-fill pricing on all compounded medications.

A recent analysis of low-dose naltrexone prescribing patterns found that patient adherence rates improved when 90-day supplies were dispensed, suggesting that bulk ordering is both financially and clinically preferable 8.

LDN Pricing Compared to Standard Naltrexone Formulations

Understanding where LDN fits in the broader naltrexone pricing picture helps clarify why compounding remains the only route for low-dose prescriptions.

Generic naltrexone 50 mg tablets, the FDA-approved formulation for opioid and alcohol use disorders, cost between $25 and $60 per month at Utah retail pharmacies and are covered by most insurance plans, including Utah Medicaid, when prescribed for substance use disorder indications. Vivitrol (naltrexone extended-release injectable, 380 mg monthly) costs approximately $1,800 to $2,200 per injection at list price, though insurance coverage for substance use disorder indications significantly reduces out-of-pocket costs for most patients 9.

LDN at $50 per month falls between generic 50 mg tablets and brand-name Vivitrol, but the comparison is somewhat misleading because these three products serve entirely different clinical purposes. The 50 mg dose blocks opioid receptors nearly completely for 24 to 72 hours and is used for addiction treatment. LDN at 1.5 mg to 4.5 mg produces a brief, partial blockade lasting roughly 4 to 6 hours, which is hypothesized to trigger a compensatory upregulation of endorphin production and modulate microglial activation in the central nervous system 10.

One approach that patients sometimes ask about is "pill splitting," cutting a 50 mg tablet into smaller pieces to approximate low doses. Clinicians strongly advise against this practice. Naltrexone 50 mg tablets are not scored, splitting produces inconsistent doses, and a 4.5 mg target dose would require splitting a tablet into roughly 11 equal pieces. This is impractical and potentially unsafe.

What Conditions Are Utah Providers Prescribing LDN For?

While LDN has no FDA-approved indication at low doses, Utah clinicians prescribe it off-label for a range of conditions. The evidence base varies considerably by indication.

Fibromyalgia has the strongest published trial data. Younger et al.'s 2009 pilot study demonstrated a 30% reduction in fibromyalgia symptoms with LDN 4.5 mg versus placebo 2. A follow-up crossover trial by Younger et al. in 2013 (N=31) replicated these findings, showing significant reductions in daily pain scores (28.8% reduction versus placebo) 11. These remain small trials, and no large-scale randomized controlled trial has been completed for this indication.

Autoimmune conditions including Crohn's disease, multiple sclerosis, and Hashimoto's thyroiditis represent a growing area of LDN prescribing. A 2007 pilot study by Jill Smith at Penn State (N=17) found that 89% of Crohn's disease patients responded to LDN at 4.5 mg, with 67% achieving remission at 12 weeks 12. A larger follow-up trial (N=40) confirmed clinical improvement in active Crohn's disease compared to placebo 13.

Chronic pain syndromes beyond fibromyalgia, including complex regional pain syndrome and chronic fatigue syndrome, are prescribed LDN by some Utah pain specialists, though published evidence for these specific indications remains limited to case series and open-label studies.

Dr. Jarrod Spencer, an integrative medicine physician in Salt Lake City, has observed: "I typically start patients at 1.5 mg nightly and increase by 1.5 mg every two weeks until reaching 4.5 mg. Most of my patients who respond notice improvement by week six to eight."

Cost Over Time: What a Year of LDN Looks Like in Utah

For Utah patients paying cash, the annual cost of LDN is straightforward to calculate. At $50 per month, a year of LDN costs $600. Adding the initial prescriber consultation ($75 to $150 for telehealth, $150 to $300 for in-person) and one to two follow-up visits ($50 to $150 each), the total first-year cost ranges from $775 to $1,200.

By comparison, first-line FDA-approved medications for fibromyalgia in Utah carry these approximate annual costs without insurance: pregabalin (Lyrica generic) at $40 to $80 per month ($480 to $960 per year), duloxetine (Cymbalta generic) at $15 to $40 per month ($180 to $480 per year), and milnacipran (Savella) at $200 to $400 per month ($2,400 to $4,800 per year) 14.

LDN's cost-effectiveness calculation depends entirely on whether it works for the individual patient. Given the 30% symptom reduction observed in published trials, a practical approach is to commit to a 12-week trial at a cost of approximately $150 for medication plus $75 to $150 for the initial consultation. If symptoms have not improved after 8 to 12 weeks at the full 4.5 mg dose, discontinuation is reasonable. LDN has no physiological withdrawal syndrome, and stopping does not require a taper.

The 503A Compounding Process for LDN in Utah

When a Utah prescriber writes an LDN prescription, it goes to a 503A compounding pharmacy, not a standard retail pharmacy. The difference matters for patients who have never used a compounding pharmacy before.

A 503A compounding pharmacy receives the prescription, verifies it with the prescriber if needed, and prepares the medication from bulk pharmaceutical-grade naltrexone powder. The pharmacist measures the precise dose (typically 1.5 mg, 3 mg, or 4.5 mg), combines it with an inert filler, and encapsulates it. The entire process is patient-specific: each batch is made for one person's prescription.

Utah requires 503A pharmacies to follow USP Chapter 795 standards for non-sterile compounding, which specify requirements for ingredient sourcing, beyond-use dating, quality assurance, and record-keeping 15. Beyond-use dates for compounded LDN capsules are typically 90 to 180 days depending on the formulation and storage conditions.

Patients picking up compounded LDN at a Utah pharmacy should expect the medication to arrive in a pharmacy-labeled vial rather than a manufacturer's box. The label will list the compounding pharmacy, prescriber, patient name, dose, and beyond-use date. Store capsules at room temperature away from moisture.

The first fill typically takes 24 to 72 hours to prepare, while refills from the same pharmacy are often available within 24 hours or same-day if the pharmacy keeps naltrexone powder in stock. Prescriptions are typically written for a 30-day or 90-day supply with refills for up to one year.